Martin L Yarmush

This inventor holds 40 USPTO granted patents and 22 published patent applications, plus 1 CIPO patent and 7 EPO patents, primarily in Tissue Engineering. Top assignees: The General Hospital Corporation, Massachusetts Institute of Technology, Rutgers, The State University of New Jersey. Active years: 1991-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Martin L Yarmush. Retrieved from https://idiyas.com/inventor/martin-l-yarmush

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 40 (Patent Applications = 22)

% Patents Active = 77.5

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 7 (Patent Applications = 9)

Average Co-Inventor Count = 3.5

ph-index = 11

Forward Citations = 666(Granted Patents)

Location History:

Sharon, MA (US) (1991 - 1999)
Piscataway, NJ (US) (2015)
Boston, MA (US) (2020 - 2023)
Newton, MA (US) (2000 - 2024)
New Brunswick, NJ (US) (2024)

Company Filing History:

25 out of 3,073

The General Hospital Corporation

patents

9 out of 8,586

Massachusetts Institute of Technology

patents

9 out of 1,496

Rutgers, The State University of New Jersey

Northeastern University

William Marsh Rice University

patents

9. 1 out of 834,513

Other

patents

where one patent can have more than one assignee

Years Active: 1991-2026

Loading Chart...

Areas of Expertise:

Tissue Preservation

3D Co-Culture

Microfluidics

Organ Perfusion

Cell Culture Systems

Biological Circuits

Electric Field Delivery

Liver Disease Treatment

Stem Cell Differentiation

Virus Precipitation

Wound Healing

Antibody Detection

40 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12692480 - Isolated adult cells, artificial organs, rehabilitated organs, research tools, organ encasements, organ perfusion systems, and methods for preparing and utilizing the same (2026-07-28),

2. 12472475 - Methods of supercooling aqueous samples (2025-11-18),

3. 12426850 - Ultrasound-guided alignment and insertion of percutaneous cannulating instruments (2025-09-30),

4. 12239126 - Methods and compositions for preserving tissues and organs (2025-03-04),

5. 12163113 - Multilayer stackable tissue culture platform for 3D co-culture (2024-12-10),

6. 11992362 - Ultrasound-guided alignment and insertion of percutaneous cannulating instruments (2024-05-28),

7. 11921109 - Microfluidic system and method for real-time measurement of antibody-antigen binding and analyte detection (2024-03-05),

8. 11590247 - System and method for electrical control of bacteria (2023-02-28),

9. 11136553 - Isolated adult cells, artificial organs, rehabilitated organs, research tools, organ encasements, organ perfusion systems, and methods for preparing and utilizing the same (2021-10-05),

10. 10668102 - Lineage differentiation of encapsulated embryonic stem cells (2020-06-02),

11. 10660979 - System and method for electrical control of bacteria (2020-05-26),

12. 10575515 - Methods and compositions for preserving tissues and organs (2020-03-03),

13. 10495631 - In vitro model of macrosteatotic (fatty) liver (2019-12-03),

14. 10363276 - Compositions, methods, and devices for treating disease (2019-07-30),

15. 10209241 - High throughput sensitization detection devices and methods (2019-02-19),

Title: Innovator Spotlight: Martin L Yarmush - Pioneering Medical Device Innovations

Introduction:

Martin L Yarmush, a distinguished inventor hailing from Sharon, MA, with an impressive portfolio of 34 patents, is revolutionizing the field of medical devices with his cutting-edge technologies.

Latest Patents:

Two of his recent patents include a "Microfluidic System for Real-Time Measurement of Antibody-Antigen Binding and Analyte Detection" and a "System for Electrical Control of Bacteria". The former focuses on using microfluidic devices for determining analyte concentrations, while the latter employs pulsed electric fields to combat microbial growth on medical implants.

Career Highlights:

Yarmush has made significant contributions while working at reputable institutions such as The General Hospital Corporation and the Massachusetts Institute of Technology. His innovative spirit and dedication to advancing medical technology have led to breakthroughs in healthcare.

Collaborations:

Throughout his career, Yarmush has collaborated with esteemed colleagues like Rene S Schloss and Mehmet Toner. Together, they have pushed the boundaries of medical device innovations, paving the way for new treatment modalities and improved patient outcomes.

Conclusion:

In conclusion, Martin L Yarmush stands as a beacon of innovation in the medical device industry, blending science and technology to develop solutions that address complex healthcare challenges. His patents and collaborations reflect a commitment to excellence and a relentless pursuit of advancements in the field.

Profile summary based on public USPTO records.